investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Preclinical Validation of U1 Adaptors for Suppression of KRAS in Pancreatic Cancer

Samuel I Gunderson

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Samuel I Gunderson

Rutgers University

New Brunswick, United States

Related projects

Monte Meier Winslow

Multiplexed in vivo drug screening: Inhibitors of metastatic seeding

Pancreas

Samuel Strober

Radiotherapy as Immunotherapy of Tumors

Pancreas

Radiation Oncology

Walter Gwang-Up Park

A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnosis, Prediction and Treatment of Chronic Pancreatitis and its associated development to Diabetes and Pancreas Cancer

Pancreas

Pathology

Fengzhi Li

An inhibitor of multiple anti-apoptotic gene products for pancreatic cancer

Pancreas

Qizhi C. Yao

A novel miR-198 replacement therapy for pancreatic cancer

Pancreas

Pathology

Donald J Buchsbaum

UAB / UMN SPORE in Pancreatic Cancer

Pancreas

Pathology

Frank Gonzalez

Xenobiotic Receptors

Pancreas Colorectum All cancers but non-melanoma skin cancer

Funda Meric-Bernstam

Training of Academic Surgical Oncologists

Pancreas

Surgery / Surgical oncology

Raghu Kalluri

Employing mouse models to translate early detection of pancreas cancer

Pancreas